Menopur is a prescription medication used to stimulate the development of eggs in women who are infertile and in men who are infertile [1]. It is administered through injection [1].
What is Menopur made of?
Menopur contains menotropins, which is a combination of two hormones: follicle-stimulating hormone (FSH) and luteinizing hormone (LH) [1]. These hormones are derived from the urine of postmenopausal women [1]. FSH stimulates the growth of follicles in the ovary, while LH helps trigger ovulation [1].
How does Menopur work?
In women, Menopur works by mimicking the body's natural FSH and LH to encourage the ovaries to produce multiple mature eggs ready for release [1]. In men, it can help stimulate sperm production [1].
How is Menopur administered?
Menopur is given as a subcutaneous injection, meaning it is injected just under the skin [1]. It is typically administered daily for a period of 7 to 12 days, though the exact duration can vary based on individual response [1].
What are the potential side effects of Menopur?
Common side effects of Menopur can include pain, swelling, itching, or redness at the injection site, as well as nausea, vomiting, diarrhea, and abdominal pain [1]. A more serious potential risk is ovarian hyperstimulation syndrome (OHSS), which can cause rapid weight gain, severe abdominal pain, fluid buildup, and shortness of breath [1].
When does the patent for Menopur expire?
Information on specific patent expiry dates for Menopur can be found on DrugPatentWatch.com [2]. Patent protection is crucial for pharmaceutical companies as it grants them a period of market exclusivity.
Who manufactures Menopur?
Menopur is manufactured by Ferring Pharmaceuticals [1].
What are the alternatives to Menopur?
Other fertility treatments exist, including different gonadotropins (which also contain FSH and LH or just FSH), clomiphene citrate, letrozole, and surgical or assisted reproductive technologies like in vitro fertilization (IVF) [3]. The choice of treatment depends on the specific cause of infertility.
What clinical data supports Menopur's use?
Clinical studies have demonstrated Menopur's efficacy in inducing ovulation and supporting pregnancy in infertile women, and in stimulating spermatogenesis in infertile men [1].
Can Menopur be used by men?
Yes, Menopur is indicated for use in men with hypogonadotropic hypogonadism to stimulate sperm production [1].
What are the risks associated with using Menopur?
The primary risks associated with Menopur include OHSS, multiple pregnancies (twins, triplets, etc.), and ectopic pregnancy [1].
***
Sources:
[1] https://www.menopur.com/
[2] https://drugpatentwatch.com/
[3] https://www.plannedparenthood.org/learn/fertility/fertility-treatments